A study on cytokine networks including IL-6 in GBM, found a trend toward survival benefit using a combined IL-4/IL-5/IL-6 serum profile, but no benefit with a partial combination (24), suggesting that combined immune-profiles may be related to GBM propagation and survival. This evidence concerns the gene IL4 and glioblastoma.